Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-01-02

AUTHORS

Takeshi Tosaki, Masahiro Okabe, Tomo Suzuki, Akihiro Shimizu, Kentaro Koike, Nobuo Tsuboi, Tetsuya Kawamura, Ryuji Ohashi, Shingo Yano, Takashi Yokoo

ABSTRACT

Idiopathic multicentric Castleman disease (iMCD) is a systemic lymphoproliferative disease involving multiple organs, including the kidneys. Membranous nephropathy (MN) has been rarely reported as a complication of iMCD. We herein report the case of a 48-year-old man with a 9-year history of iMCD that was complicated by treatment-resistant nephrotic syndrome due to MN. The first renal biopsy performed at the age of 45 years showed diffuse and global MN with a mild glomerular endothelial injury. He was treated with combined therapy of corticosteroids, immunosuppressants, and tocilizumab, an anti-interleukin-6 (IL-6) receptor monoclonal antibody, which was administered every 2–3 weeks. However, nephrotic syndrome persisted, and renal impairment slowly worsened. Serial biopsy performed at 3 years after the first biopsy confirmed advanced lesions of both MN-related and glomerular endothelial injuries. Modification of the therapeutic strategy to weekly administration of tocilizumab gradually led to the remission of proteinuria, allowing the termination of corticosteroids. Thus, the present case suggests a close link between excessive IL-6 actions and the development of glomerular lesions in iMCD. Successful treatment by strict inhibition of IL-6 actions, in this case, may provide a clue for deciding the therapeutic strategy for severe renal complications associated with iMCD. More... »

PAGES

265-272

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13730-020-00559-6

DOI

http://dx.doi.org/10.1007/s13730-020-00559-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1134281228

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33389670


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Castleman Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerulonephritis, Membranous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombotic Microangiopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tosaki", 
        "givenName": "Takeshi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okabe", 
        "givenName": "Masahiro", 
        "id": "sg:person.0662566237.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662566237.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412764.2", 
          "name": [
            "Department of Nephrology, Kameda Medical Center, Kamogawa, Japan", 
            "Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Tomo", 
        "id": "sg:person.01006223635.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006223635.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimizu", 
        "givenName": "Akihiro", 
        "id": "sg:person.01131241374.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131241374.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koike", 
        "givenName": "Kentaro", 
        "id": "sg:person.0753403513.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753403513.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsuboi", 
        "givenName": "Nobuo", 
        "id": "sg:person.01205054154.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205054154.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawamura", 
        "givenName": "Tetsuya", 
        "id": "sg:person.0676043416.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676043416.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Pathology, Nippon Medical School Musashi-Kosugi Hospital, Kawasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459842.6", 
          "name": [
            "Department of Diagnostic Pathology, Nippon Medical School Musashi-Kosugi Hospital, Kawasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohashi", 
        "givenName": "Ryuji", 
        "id": "sg:person.01007566226.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007566226.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yano", 
        "givenName": "Shingo", 
        "id": "sg:person.01265010246.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265010246.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoo", 
        "givenName": "Takashi", 
        "id": "sg:person.01122657316.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122657316.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13730-018-0336-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103995528", 
          "https://doi.org/10.1007/s13730-018-0336-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13730-020-00511-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1129666802", 
          "https://doi.org/10.1007/s13730-020-00511-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2012.207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034028134", 
          "https://doi.org/10.1038/modpathol.2012.207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13730-019-00399-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1113808759", 
          "https://doi.org/10.1007/s13730-019-00399-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-01-02", 
    "datePublishedReg": "2021-01-02", 
    "description": "Idiopathic multicentric Castleman disease (iMCD) is a systemic lymphoproliferative disease involving multiple organs, including the kidneys. Membranous nephropathy (MN) has been rarely reported as a complication of iMCD. We herein report the case of a 48-year-old man with a 9-year history of iMCD that was complicated by treatment-resistant nephrotic syndrome due to MN. The first renal biopsy performed at the age of 45\u00a0years showed diffuse and global MN with a mild glomerular endothelial injury. He was treated with combined therapy of corticosteroids, immunosuppressants, and tocilizumab, an anti-interleukin-6 (IL-6) receptor monoclonal antibody, which was administered every 2\u20133\u00a0weeks. However, nephrotic syndrome persisted, and renal impairment slowly worsened. Serial biopsy performed at 3\u00a0years after the first biopsy confirmed advanced lesions of both MN-related and glomerular endothelial injuries. Modification of the therapeutic strategy to weekly administration of tocilizumab gradually led to the remission of proteinuria, allowing the termination of corticosteroids. Thus, the present case suggests a close link between excessive IL-6 actions and the development of glomerular lesions in iMCD. Successful treatment by strict inhibition of IL-6 actions, in this case, may provide a clue for deciding the therapeutic strategy for severe renal complications associated with iMCD.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13730-020-00559-6", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1050419", 
        "issn": [
          "2192-4449"
        ], 
        "name": "CEN Case Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "idiopathic multicentric Castleman disease", 
      "glomerular endothelial injury", 
      "membranous nephropathy", 
      "IL-6 action", 
      "multicentric Castleman's disease", 
      "endothelial injury", 
      "nephrotic syndrome", 
      "Castleman's disease", 
      "therapeutic strategies", 
      "thrombotic microangiopathy-like lesions", 
      "treatment-resistant nephrotic syndrome", 
      "systemic lymphoproliferative disease", 
      "therapy of corticosteroids", 
      "severe renal complications", 
      "remission of proteinuria", 
      "first renal biopsy", 
      "receptor monoclonal antibody", 
      "renal impairment", 
      "renal complications", 
      "weekly administration", 
      "renal biopsy", 
      "first biopsy", 
      "serial biopsies", 
      "lymphoproliferative disease", 
      "glomerular lesions", 
      "successful treatment", 
      "advanced lesions", 
      "multiple organs", 
      "tocilizumab", 
      "biopsy", 
      "monoclonal antibodies", 
      "lesions", 
      "disease", 
      "present case", 
      "corticosteroids", 
      "nephropathy", 
      "complications", 
      "syndrome", 
      "injury", 
      "remission", 
      "proteinuria", 
      "strict inhibition", 
      "patients", 
      "immunosuppressants", 
      "therapy", 
      "years", 
      "kidney", 
      "administration", 
      "cases", 
      "impairment", 
      "weeks", 
      "antibodies", 
      "age", 
      "men", 
      "treatment", 
      "organs", 
      "inhibition", 
      "action", 
      "diffuse", 
      "history", 
      "strategies", 
      "close link", 
      "termination", 
      "clues", 
      "development", 
      "modification", 
      "link"
    ], 
    "name": "Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease", 
    "pagination": "265-272", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1134281228"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13730-020-00559-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33389670"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13730-020-00559-6", 
      "https://app.dimensions.ai/details/publication/pub.1134281228"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_877.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13730-020-00559-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13730-020-00559-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13730-020-00559-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13730-020-00559-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13730-020-00559-6'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      21 PREDICATES      104 URIs      92 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13730-020-00559-6 schema:about N197727876c2b4ea38c13242c4edd0d5f
2 N4cb4f9736e0f475f8a0ddb6ba2e52c6e
3 N6d778f4871204f50a9fdabef3a5a9db9
4 N7d919495e4b649e49faf0ad0067537db
5 N9734c472aa63450687c67f33d221a5bd
6 Naa0a0ef8f3d5497ab8b2596a5ceae544
7 Nbd33ad9ab65d4d409456e34a84537b7f
8 Ned064f80f7f348759904532cff33aef6
9 anzsrc-for:11
10 anzsrc-for:1103
11 schema:author N3969ab7863e04384bd4a56c7304a9671
12 schema:citation sg:pub.10.1007/s13730-018-0336-z
13 sg:pub.10.1007/s13730-019-00399-z
14 sg:pub.10.1007/s13730-020-00511-8
15 sg:pub.10.1038/modpathol.2012.207
16 schema:datePublished 2021-01-02
17 schema:datePublishedReg 2021-01-02
18 schema:description Idiopathic multicentric Castleman disease (iMCD) is a systemic lymphoproliferative disease involving multiple organs, including the kidneys. Membranous nephropathy (MN) has been rarely reported as a complication of iMCD. We herein report the case of a 48-year-old man with a 9-year history of iMCD that was complicated by treatment-resistant nephrotic syndrome due to MN. The first renal biopsy performed at the age of 45 years showed diffuse and global MN with a mild glomerular endothelial injury. He was treated with combined therapy of corticosteroids, immunosuppressants, and tocilizumab, an anti-interleukin-6 (IL-6) receptor monoclonal antibody, which was administered every 2–3 weeks. However, nephrotic syndrome persisted, and renal impairment slowly worsened. Serial biopsy performed at 3 years after the first biopsy confirmed advanced lesions of both MN-related and glomerular endothelial injuries. Modification of the therapeutic strategy to weekly administration of tocilizumab gradually led to the remission of proteinuria, allowing the termination of corticosteroids. Thus, the present case suggests a close link between excessive IL-6 actions and the development of glomerular lesions in iMCD. Successful treatment by strict inhibition of IL-6 actions, in this case, may provide a clue for deciding the therapeutic strategy for severe renal complications associated with iMCD.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf N6c9b55ab1c6949e3a5157d576250600b
22 N8c5fa75f5f1e4eea95f72dbd90be4362
23 sg:journal.1050419
24 schema:keywords Castleman's disease
25 IL-6 action
26 action
27 administration
28 advanced lesions
29 age
30 antibodies
31 biopsy
32 cases
33 close link
34 clues
35 complications
36 corticosteroids
37 development
38 diffuse
39 disease
40 endothelial injury
41 first biopsy
42 first renal biopsy
43 glomerular endothelial injury
44 glomerular lesions
45 history
46 idiopathic multicentric Castleman disease
47 immunosuppressants
48 impairment
49 inhibition
50 injury
51 kidney
52 lesions
53 link
54 lymphoproliferative disease
55 membranous nephropathy
56 men
57 modification
58 monoclonal antibodies
59 multicentric Castleman's disease
60 multiple organs
61 nephropathy
62 nephrotic syndrome
63 organs
64 patients
65 present case
66 proteinuria
67 receptor monoclonal antibody
68 remission
69 remission of proteinuria
70 renal biopsy
71 renal complications
72 renal impairment
73 serial biopsies
74 severe renal complications
75 strategies
76 strict inhibition
77 successful treatment
78 syndrome
79 systemic lymphoproliferative disease
80 termination
81 therapeutic strategies
82 therapy
83 therapy of corticosteroids
84 thrombotic microangiopathy-like lesions
85 tocilizumab
86 treatment
87 treatment-resistant nephrotic syndrome
88 weekly administration
89 weeks
90 years
91 schema:name Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease
92 schema:pagination 265-272
93 schema:productId N047d210195294346baaa71dfc61f7c6c
94 N3438fa56f9a9443c849c24ab3c028ff7
95 N869e607ef7404ad9b2f6bc55ce8bf767
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134281228
97 https://doi.org/10.1007/s13730-020-00559-6
98 schema:sdDatePublished 2022-08-04T17:09
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N8d7f15a1f2ee4652a7f2f71b1b12a3ac
101 schema:url https://doi.org/10.1007/s13730-020-00559-6
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N047d210195294346baaa71dfc61f7c6c schema:name doi
106 schema:value 10.1007/s13730-020-00559-6
107 rdf:type schema:PropertyValue
108 N0f177e5330274ae8b29ddd891d2f6916 rdf:first sg:person.0753403513.08
109 rdf:rest Naeac9ab9816d4dbeaad88555c043eca2
110 N197727876c2b4ea38c13242c4edd0d5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Castleman Disease
112 rdf:type schema:DefinedTerm
113 N2119dc4413fe400c8712ad77d8c99dce rdf:first sg:person.01122657316.61
114 rdf:rest rdf:nil
115 N3438fa56f9a9443c849c24ab3c028ff7 schema:name pubmed_id
116 schema:value 33389670
117 rdf:type schema:PropertyValue
118 N38d1eb7b2e56418bb62dd65d2696ebc1 rdf:first sg:person.01006223635.53
119 rdf:rest Ne722e3fafaa84d119e1a06fc19356e1f
120 N3969ab7863e04384bd4a56c7304a9671 rdf:first Nbf63019b70544e7a94105367cd1d979e
121 rdf:rest N47c96edc98d545b693f9f36f379612f5
122 N47c96edc98d545b693f9f36f379612f5 rdf:first sg:person.0662566237.24
123 rdf:rest N38d1eb7b2e56418bb62dd65d2696ebc1
124 N4cb4f9736e0f475f8a0ddb6ba2e52c6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N5b24129514b44231b15bc86e0782f204 rdf:first sg:person.01007566226.53
128 rdf:rest N970e2d632ec74914b426000d00a8faf3
129 N6c9b55ab1c6949e3a5157d576250600b schema:issueNumber 2
130 rdf:type schema:PublicationIssue
131 N6d778f4871204f50a9fdabef3a5a9db9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Antibodies, Monoclonal, Humanized
133 rdf:type schema:DefinedTerm
134 N7d919495e4b649e49faf0ad0067537db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Treatment Outcome
136 rdf:type schema:DefinedTerm
137 N869e607ef7404ad9b2f6bc55ce8bf767 schema:name dimensions_id
138 schema:value pub.1134281228
139 rdf:type schema:PropertyValue
140 N8c5fa75f5f1e4eea95f72dbd90be4362 schema:volumeNumber 10
141 rdf:type schema:PublicationVolume
142 N8d7f15a1f2ee4652a7f2f71b1b12a3ac schema:name Springer Nature - SN SciGraph project
143 rdf:type schema:Organization
144 N913b999d6d924fb686de8a17ea431466 rdf:first sg:person.0676043416.38
145 rdf:rest N5b24129514b44231b15bc86e0782f204
146 N970e2d632ec74914b426000d00a8faf3 rdf:first sg:person.01265010246.42
147 rdf:rest N2119dc4413fe400c8712ad77d8c99dce
148 N9734c472aa63450687c67f33d221a5bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Humans
150 rdf:type schema:DefinedTerm
151 Naa0a0ef8f3d5497ab8b2596a5ceae544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Thrombotic Microangiopathies
153 rdf:type schema:DefinedTerm
154 Naeac9ab9816d4dbeaad88555c043eca2 rdf:first sg:person.01205054154.42
155 rdf:rest N913b999d6d924fb686de8a17ea431466
156 Nbd33ad9ab65d4d409456e34a84537b7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 Nbf63019b70544e7a94105367cd1d979e schema:affiliation grid-institutes:grid.411898.d
160 schema:familyName Tosaki
161 schema:givenName Takeshi
162 rdf:type schema:Person
163 Ne722e3fafaa84d119e1a06fc19356e1f rdf:first sg:person.01131241374.35
164 rdf:rest N0f177e5330274ae8b29ddd891d2f6916
165 Ned064f80f7f348759904532cff33aef6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Glomerulonephritis, Membranous
167 rdf:type schema:DefinedTerm
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
172 schema:name Clinical Sciences
173 rdf:type schema:DefinedTerm
174 sg:journal.1050419 schema:issn 2192-4449
175 schema:name CEN Case Reports
176 schema:publisher Springer Nature
177 rdf:type schema:Periodical
178 sg:person.01006223635.53 schema:affiliation grid-institutes:grid.412764.2
179 schema:familyName Suzuki
180 schema:givenName Tomo
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006223635.53
182 rdf:type schema:Person
183 sg:person.01007566226.53 schema:affiliation grid-institutes:grid.459842.6
184 schema:familyName Ohashi
185 schema:givenName Ryuji
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007566226.53
187 rdf:type schema:Person
188 sg:person.01122657316.61 schema:affiliation grid-institutes:grid.411898.d
189 schema:familyName Yokoo
190 schema:givenName Takashi
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122657316.61
192 rdf:type schema:Person
193 sg:person.01131241374.35 schema:affiliation grid-institutes:grid.411898.d
194 schema:familyName Shimizu
195 schema:givenName Akihiro
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131241374.35
197 rdf:type schema:Person
198 sg:person.01205054154.42 schema:affiliation grid-institutes:grid.411898.d
199 schema:familyName Tsuboi
200 schema:givenName Nobuo
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205054154.42
202 rdf:type schema:Person
203 sg:person.01265010246.42 schema:affiliation grid-institutes:grid.411898.d
204 schema:familyName Yano
205 schema:givenName Shingo
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265010246.42
207 rdf:type schema:Person
208 sg:person.0662566237.24 schema:affiliation grid-institutes:grid.411898.d
209 schema:familyName Okabe
210 schema:givenName Masahiro
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662566237.24
212 rdf:type schema:Person
213 sg:person.0676043416.38 schema:affiliation grid-institutes:grid.411898.d
214 schema:familyName Kawamura
215 schema:givenName Tetsuya
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676043416.38
217 rdf:type schema:Person
218 sg:person.0753403513.08 schema:affiliation grid-institutes:grid.411898.d
219 schema:familyName Koike
220 schema:givenName Kentaro
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753403513.08
222 rdf:type schema:Person
223 sg:pub.10.1007/s13730-018-0336-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1103995528
224 https://doi.org/10.1007/s13730-018-0336-z
225 rdf:type schema:CreativeWork
226 sg:pub.10.1007/s13730-019-00399-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1113808759
227 https://doi.org/10.1007/s13730-019-00399-z
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s13730-020-00511-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129666802
230 https://doi.org/10.1007/s13730-020-00511-8
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/modpathol.2012.207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034028134
233 https://doi.org/10.1038/modpathol.2012.207
234 rdf:type schema:CreativeWork
235 grid-institutes:grid.411898.d schema:alternateName Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
236 Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan
237 schema:name Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
238 Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, Japan
239 rdf:type schema:Organization
240 grid-institutes:grid.412764.2 schema:alternateName Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan
241 schema:name Department of Nephrology, Kameda Medical Center, Kamogawa, Japan
242 Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan
243 rdf:type schema:Organization
244 grid-institutes:grid.459842.6 schema:alternateName Department of Diagnostic Pathology, Nippon Medical School Musashi-Kosugi Hospital, Kawasaki, Japan
245 schema:name Department of Diagnostic Pathology, Nippon Medical School Musashi-Kosugi Hospital, Kawasaki, Japan
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...